174 related articles for article (PubMed ID: 18196745)
1. Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.
Hampel V; Schwarz B; Kempf C; Köstlin R; Schillinger U; Küchenhoff H; Fenske N; Brill T; Hirschberger J
J Vet Intern Med; 2007; 21(6):1340-6. PubMed ID: 18196745
[TBL] [Abstract][Full Text] [Related]
2. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease.
Ballin AC; Schulz B; Helps C; Sauter-Louis C; Mueller RS; Hartmann K
Vet J; 2014 Dec; 202(3):466-70. PubMed ID: 25457261
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
Matsumoto H; Teshima T; Iizuka Y; Sakusabe A; Takahashi D; Amimoto A; Koyama H
Res Vet Sci; 2018 Dec; 121():53-58. PubMed ID: 30359811
[TBL] [Abstract][Full Text] [Related]
4. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats.
de Mari K; Maynard L; Sanquer A; Lebreux B; Eun HM
J Vet Intern Med; 2004; 18(4):477-82. PubMed ID: 15320583
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration.
Paltrinieri S; Crippa A; Comerio T; Angioletti A; Roccabianca P
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):68-74. PubMed ID: 17521745
[TBL] [Abstract][Full Text] [Related]
8. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.
Bracklein T; Theise S; Metzler A; Spiess BM; Richter M
Am J Vet Res; 2006 Jun; 67(6):1025-32. PubMed ID: 16740097
[TBL] [Abstract][Full Text] [Related]
9. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.
Litzlbauer P; Weber K; Mueller RS
Cytokine; 2014 Mar; 66(1):54-9. PubMed ID: 24548425
[TBL] [Abstract][Full Text] [Related]
10. Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs.
Ishiwata K; Minagawa T; Kajimoto T
J Vet Med Sci; 1998 Aug; 60(8):911-7. PubMed ID: 9764403
[TBL] [Abstract][Full Text] [Related]
11. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
Tanabe T; Yamamoto JK
J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
Haid C; Kaps S; Gönczi E; Hässig M; Metzler A; Spiess BM; Richter M
Vet Ophthalmol; 2007; 10(5):278-84. PubMed ID: 17760705
[TBL] [Abstract][Full Text] [Related]
13. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1.
Siebeck N; Hurley DJ; Garcia M; Greene CE; Köstlin RG; Moore PA; Dietrich UM
Am J Vet Res; 2006 Aug; 67(8):1406-11. PubMed ID: 16881854
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of viremia, proviral load and cytokine profile in naturally feline immunodeficiency virus infected cats treated with two different protocols of recombinant feline interferon omega.
Leal RO; Gil S; Duarte A; McGahie D; Sepúlveda N; Niza MM; Tavares L
Res Vet Sci; 2015 Apr; 99():87-95. PubMed ID: 25747956
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro.
Priosoeryanto BP; Tateyama S; Yamaguchi R; Uchida K
Can J Vet Res; 1995 Jan; 59(1):67-9. PubMed ID: 7704845
[TBL] [Abstract][Full Text] [Related]
16.
Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
Front Vet Sci; 2019; 6():104. PubMed ID: 31024941
[No Abstract] [Full Text] [Related]
17. Receptors for recombinant feline interferon-omega in hemocytes of the Japanese pearl oyster Pinctada fucata martensii.
Miyazaki T; Taniguchi T; Hirayama J; Nozawa N
Dis Aquat Organ; 2002 Aug; 51(2):135-8. PubMed ID: 12363085
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial results on the use of a recombinant feline interferon-omega to protect Japanese pearl oysters Pinctada fucata martensii from akoya-virus infection.
Miyazaki T; Nozawa N; Kobayashi T
Dis Aquat Organ; 2000 Oct; 43(1):15-26. PubMed ID: 11129377
[TBL] [Abstract][Full Text] [Related]
19. Use of recombinant interferon omega in feline retrovirosis: from theory to practice.
Doménech A; Miró G; Collado VM; Ballesteros N; Sanjosé L; Escolar E; Martin S; Gomez-Lucia E
Vet Immunol Immunopathol; 2011 Oct; 143(3-4):301-6. PubMed ID: 21719116
[TBL] [Abstract][Full Text] [Related]
20. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study.
Jahnke A; Hirschberger J; Fischer C; Brill T; Köstlin R; Plank C; Küchenhoff H; Krieger S; Kamenica K; Schillinger U
J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):599-606. PubMed ID: 18045346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
